Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.94
Delayed Data
As of 4:00pm ET
 +0.58 / +0.95%
Today’s Change
54.01
Today|||52-Week Range
68.12
-1.09%
Year-to-Date
These 3 Dividend Stocks Are Ridiculously Cheap
10:51am / MotleyFool.com - Paid Partner Content
Gilead (GILD) Announces Data on Combination Therapy for HIV
Feb 14 / Zacks.com - Paid Partner Content
AbbVie Declares Quarterly Dividend
Feb 21 / GuruFocus News - Paid Partner Content
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Feb 13 / Zacks.com - Paid Partner Content
Green Square Capital Llc Buys Landmark Infrastructure Partners LP, iShares Short-Term...
Feb 17 / GuruFocus News - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Feb 13 / MotleyFool.com - Paid Partner Content
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
Feb 10 / MotleyFool.com - Paid Partner Content
Why I Just Bought AbbVie Stock
Feb 15 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly
Feb 10 / MotleyFool.com - Paid Partner Content
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next De...
Feb 15 / MotleyFool.com - Paid Partner Content